1
|
Ilicic K, Dollinger G, Dombrowsky A, Greubel C, Girst S, Sammer M, Siebenwirth C, Schmid E, Friedrich T, Kundrát P, Friedland W, Scholz M, Combs SE, Schmid TE, Reindl J. Enhanced RBE of Particle Radiation Depends on Beam Size in the Micrometer Range. Radiat Res 2024; 201:140-149. [PMID: 38214379 DOI: 10.1667/rade-23-00217.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 12/01/2023] [Indexed: 01/13/2024]
Abstract
High-linear energy transfer (LET) radiation, such as heavy ions is associated with a higher relative biological effectiveness (RBE) than low-LET radiation, such as photons. Irradiation with low- and high-LET particles differ in the interaction with the cellular matter and therefore in the spatial dose distribution. When a single high-LET particle interacts with matter, it results in doses of up to thousands of gray (Gy) locally concentrated around the ion trajectory, whereas the mean dose averaged over the target, such as a cell nucleus is only in the range of a Gy. DNA damage therefore accumulates in this small volume. In contrast, up to hundreds of low-LET particle hits are required to achieve the same mean dose, resulting in a quasi-homogeneous damage distribution throughout the cell nucleus. In this study, we investigated the dependence of RBE from different spatial dose depositions using different focused beam spot sizes of proton radiation with respect to the induction of chromosome aberrations and clonogenic cell survival. Human-hamster hybrid (AL) as well as Chinese hamster ovary cells (CHO-K1) were irradiated with focused low LET protons of 20 MeV (LET = 2.6 keV/µm) beam energy with a mean dose of 1.7 Gy in a quadratic matrix pattern with point spacing of 5.4 × 5.4 µm2 and 117 protons per matrix point at the ion microbeam SNAKE using different beam spot sizes between 0.8 µm and 2.8 µm (full width at half maximum). The dose-response curves of X-ray reference radiation were used to determine the RBE after a 1.7 Gy dose of radiation. The RBE for the induction of dicentric chromosomes and cell inactivation was increased after irradiation with the smallest beam spot diameter (0.8 µm for chromosome aberration experiments and 1.0 µm for cell survival experiments) compared to homogeneous proton radiation but was still below the RBE of a corresponding high LET single ion hit. By increasing the spot size to 1.6-1.8 µm, the RBE decreased but was still higher than for homogeneously distributed protons. By further increasing the spot size to 2.7-2.8 µm, the RBE was no longer different from the homogeneous radiation. Our experiments demonstrate that varying spot size of low-LET radiation gradually modifies the RBE. This underlines that a substantial fraction of enhanced RBE originates from inhomogeneous energy concentrations on the µm scale (mean intertrack distances of low-LET particles below 0.1 µm) and quantifies the link between such energy concentration and RBE. The missing fraction of RBE enhancement when comparing with high-LET ions is attributed to the high inner track energy deposition on the nanometer scale. The results are compared with model results of PARTRAC and LEM for chromosomal aberration and cell survival, respectively, which suggest mechanistic interpretations of the observed radiation effects.
Collapse
Affiliation(s)
- K Ilicic
- Institute of Radiation Medicine (IRM), Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Department of Radiation Oncology, School of Medicine, Technische Universität München, Germany
| | - G Dollinger
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| | - A Dombrowsky
- Institute of Radiation Medicine (IRM), Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Department of Radiation Oncology, School of Medicine, Technische Universität München, Germany
| | - C Greubel
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| | - S Girst
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| | - M Sammer
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| | - C Siebenwirth
- Department of Radiation Oncology, School of Medicine, Technische Universität München, Germany
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| | - E Schmid
- Department for Anatomy and Cell Biology, Ludwig-Maximilians Universität München, Germany
| | - T Friedrich
- GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Darmstadt, Germany
| | - P Kundrát
- GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Darmstadt, Germany
| | - W Friedland
- Institute of Radiation Medicine (IRM), Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
| | - M Scholz
- GSI Helmholtz Center for Heavy Ion Research, Department of Biophysics, Darmstadt, Germany
| | - S E Combs
- Institute of Radiation Medicine (IRM), Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Department of Radiation Oncology, School of Medicine, Technische Universität München, Germany
| | - T E Schmid
- Institute of Radiation Medicine (IRM), Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Department of Radiation Oncology, School of Medicine, Technische Universität München, Germany
| | - J Reindl
- Institute for Applied Physics and Measurement Technology, Universität der Bundeswehr München, Neubiberg, Germany
| |
Collapse
|
2
|
Friedrich T, Pfuhl T, Scholz M. Spectral composition of secondary electrons based on the Kiefer-Straaten ion track structure model. Phys Med Biol 2024; 69:025013. [PMID: 38118162 DOI: 10.1088/1361-6560/ad1765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Accepted: 12/20/2023] [Indexed: 12/22/2023]
Abstract
The major part of energy deposition of ionizing radiation is caused by secondary electrons, independent of the primary radiation type. However, their spatial concentration and their spectral properties strongly depend on the primary radiation type and finally determine the pattern of molecular damage e.g. to biological targets as the DNA, and thus the final effect of the radiation exposure. To describe the physical and to predict the biological consequences of charged ion irradiation, amorphous track structure approaches have proven to be pragmatic and helpful. There, the local dose deposition in the ion track is equated by considering the emission and slowing down of the secondary electrons from the primary particle track. In the present work we exploit the model of Kiefer and Straaten and derive the spectral composition of secondary electrons as function of the distance to the track center. The spectral composition indicates differences to spectra of low linear energy transfer (LET) photon radiation, which we confirm by a comparison with Monte Carlo studies. We demonstrate that the amorphous track structure approach provides a simple tool for evaluating the spectral electron properties within the track structure. Predictions of the LET of electrons across the track structure as well as the electronic dose build-up effect are derived. Implications for biological effects and corresponding predicting models based on amorphous track structure are discussed.
Collapse
Affiliation(s)
- T Friedrich
- GSI Helmholtzzentrum für Schwerionenforschung, Planckstraße 1, D-64291 Darmstadt, Germany
| | - T Pfuhl
- GSI Helmholtzzentrum für Schwerionenforschung, Planckstraße 1, D-64291 Darmstadt, Germany
| | - M Scholz
- GSI Helmholtzzentrum für Schwerionenforschung, Planckstraße 1, D-64291 Darmstadt, Germany
| |
Collapse
|
3
|
Schneider K, Breuer G, Luibl L, Paulsen F, Scholz M, Burger PHM. Vulnerable in the end - Longitudinal study among medical students on mental health and personal and work-related resources over a 5.5-year-period. Ann Anat 2023; 250:152155. [PMID: 37683899 DOI: 10.1016/j.aanat.2023.152155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 08/24/2023] [Accepted: 08/25/2023] [Indexed: 09/10/2023]
Abstract
BACKGROUND Mental health problems are common in medical professionals and their development already starts at the undergraduate level. Studies on medical students can replicate higher prevalence for depression and burnout in this group, but they normally compare semester cohorts in an anonymized, cross-sectional approach and without a preventive perspective. METHODS We surveyed medical students at the beginning and end of their medical curriculum and collected data on burnout, depressivity, work related experience and salutogenesis parameters with validated self-administered questionnaires. Most remarkably we obtained the data from the same 58 individuals after 5.5 years, representing data of the highest quality in order to compare the mental health status at the beginning and the end of our students´ medical curriculum. RESULTS Our results not only show a severe exacerbation of physical, mental and emotional burnout in the participants at the end of their studies. The students also do not seem to have sufficient personal (resilience) or social resources (e.g. experience of social support) for coping with their mental health problems around the time of their graduation. CONCLUSIONS Our participants reflect a development of mental health during their medical studies at university that is paving the way to the devastating prevalence of mental disorders and suicide in health professionals. From our results we derive an urgent need to integrate self-care and active coping in the learning goals of medical curricula.
Collapse
Affiliation(s)
- K Schneider
- Department of Functional and Clinical Anatomy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
| | - G Breuer
- REGIOMED Hospital Group, Coburg Hospital, Coburg, Germany
| | - L Luibl
- Child and Adolescent Psychiatry, University Hospital, Erlangen, Germany
| | - F Paulsen
- Triaplus Zugersee Hospital, Center of Psychiatry and Psychotherapy, Oberwil, Zug, Switzerland
| | - M Scholz
- Department of Functional and Clinical Anatomy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
| | - P H M Burger
- Triaplus Zugersee Hospital, Center of Psychiatry and Psychotherapy, Oberwil, Zug, Switzerland
| |
Collapse
|
4
|
Tkach O, Vo TP, Fedchenko O, Medjanik K, Lytvynenko Y, Babenkov S, Vasilyev D, Nguyen QL, Peixoto TRF, Gloskowskii A, Schlueter C, Chernov S, Hoesch M, Kutnyakhov D, Scholz M, Wenthaus L, Wind N, Marotzke S, Winkelmann A, Rossnagel K, Minár J, Elmers HJ, Schönhense G. Circular dichroism in hard X-ray photoelectron diffraction observed by time-of-flight momentum microscopy. Ultramicroscopy 2023; 250:113750. [PMID: 37178606 DOI: 10.1016/j.ultramic.2023.113750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Revised: 04/01/2023] [Accepted: 05/04/2023] [Indexed: 05/15/2023]
Abstract
X-ray photoelectron diffraction (XPD) is a powerful technique that yields detailed structural information of solids and thin films that complements electronic structure measurements. Among the strongholds of XPD we can identify dopant sites, track structural phase transitions, and perform holographic reconstruction. High-resolution imaging of kll-distributions (momentum microscopy) presents a new approach to core-level photoemission. It yields full-field kx-ky XPD patterns with unprecedented acquisition speed and richness in details. Here, we show that beyond the pure diffraction information, XPD patterns exhibit pronounced circular dichroism in the angular distribution (CDAD) with asymmetries up to 80%, alongside with rapid variations on a small kll-scale (0.1 Å-1). Measurements with circularly-polarized hard X-rays (hν = 6 keV) for a number of core levels, including Si, Ge, Mo and W, prove that core-level CDAD is a general phenomenon that is independent of atomic number. The fine structure in CDAD is more pronounced compared to the corresponding intensity patterns. Additionally, they obey the same symmetry rules as found for atomic and molecular species, and valence bands. The CD is antisymmetric with respect to the mirror planes of the crystal, whose signatures are sharp zero lines. Calculations using both the Bloch-wave approach and one-step photoemission reveal the origin of the fine structure that represents the signature of Kikuchi diffraction. To disentangle the roles of photoexcitation and diffraction, XPD has been implemented into the Munich SPRKKR package to unify the one-step model of photoemission and multiple scattering theory.
Collapse
Affiliation(s)
- O Tkach
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany; Sumy State University, Rymskogo-Korsakova 2, 40007 Sumy, Ukraine.
| | - T-P Vo
- New Technologies - Research Centre, Univ. of West Bohemia, 30100 Pilsen, Czech Republic
| | - O Fedchenko
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| | - K Medjanik
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| | - Y Lytvynenko
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany; Institute of Magnetism of the NAS of Ukraine and MES of Ukraine, 03142 Kyiv, Ukraine
| | - S Babenkov
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| | - D Vasilyev
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| | - Q L Nguyen
- Linac Coherent Light Source, SLAC National Accelerator Laboratory, Menlo Park, CA 94025, USA
| | - T R F Peixoto
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - A Gloskowskii
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - C Schlueter
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Chernov
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M Hoesch
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - D Kutnyakhov
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M Scholz
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Wenthaus
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - N Wind
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany; Institut für Experimentalphysik, Universität Hamburg, 22761 Hamburg, Germany
| | - S Marotzke
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany; Institut für Experimentelle und Angewandte Physik, Christian-Albrechts-Universität zu Kiel, 24098 Kiel, Germany
| | - A Winkelmann
- Academic Centre for Materials and Nanotechn., Univ. of Science and Technology, Kraków, Poland
| | - K Rossnagel
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany; Institut für Experimentelle und Angewandte Physik, Christian-Albrechts-Universität zu Kiel, 24098 Kiel, Germany
| | - J Minár
- New Technologies - Research Centre, Univ. of West Bohemia, 30100 Pilsen, Czech Republic
| | - H-J Elmers
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| | - G Schönhense
- Johannes Gutenberg-Universität, Institut für Physik, 55128 Mainz, Germany
| |
Collapse
|
5
|
Filipova V, Stuerzebecher PE, Kralisch S, Schubert MR, Hoffmann A, Oliveira F, Sheikh B, Blueher M, Kogel A, Scholz M, Miehle K, Ebert T, Laufs U, Toenjes A, Boeckel JN. Leptin mediates protective effects on the vasculature. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.3057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction and purpose
Lipodystrophy (LD) syndromes are characterized by the loss of adipose tissue resulting in metabolic complications and accelerated atherosclerosis. The systemic concentration of the adipokine leptin is reduced in LD as a result of adipose tissue deficiency. A therapeutical option to treat LD is the substitution of leptin, which improves metabolic complications and reduces mortality. However, the vascular effects of leptin remain largely unknown.
Here we analyze the direct effects of leptin on the vascular system and the development of atherosclerosis.
Methods and results
Treatment of human endothelial cells (ECs) with leptin reduced endothelial inflammation and the process of endothelial-to-mesenchymal transition (EndMT) (CNN1, −41.4%, p<0.05, n=4). In addition, leptin administration prevented the EndMT-induced increase of endothelial permeability. The protective effect of leptin on EndMT was confirmed in vivo in a combined lipodystrophic and atherosclerosis-prone mouse model (LDLR−/−; aP2-nSrebp1c). Treatment of the mice with leptin (3.0 mg/kg body weight daily for 8 weeks) decreased EndMT. Leptin showed no effect on plaques size but reduced the protrusion of plaques in atherosclerotic areas of the aortic roots (−31%, p<0.05, n=4–6).
Cytokine screening revealed an increase of the growth differentiation factor 15 (GDF15) in serum of LD patients (+26.2%, p<0.05, n=53–58) and in ECs after EndMT (+138%, p<0.05, n=6743–10920). This increase was reversed using leptin treatment in ECs undergoing EndMT, in the LD mice model, and in LD patients after 4 weeks of leptin administration. Indeed, treatment of endothelial cells with GDF15 induced EndMT (CNN1, +7.7-fold-control, p<0.05, n=3), and impaired EC barrier function. Neutralizing antibodies targeting GDF15 inhibited EndMT-mediated expression of mesenchymal genes (CNN1, −54%, p<0.05, n=4). The treatment of ECs with serum from LD patients induced EndMT and the increase of mesenchymal marker expression was inhibited with additional administration with neutralizing antibodies targeting GDF15 (CNN1, −28%, p<0.05, n=3).
Conclusion
Our findings indicate that EndMT is part of the cardiovascular disease progression in lipodystrophy syndromes. Leptin treatment has direct protective vascular effects by preventing inflammation, EndMT, and maintaining endothelial integrity.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Collapse
Affiliation(s)
- V Filipova
- University Hospital Leipzig , Leipzig , Germany
| | | | - S Kralisch
- University of Leipzig Medical Center , Leipzig , Germany
| | | | - A Hoffmann
- University Hospital Wuerzburg , Wuerzburg , Germany
| | - F Oliveira
- University of Leipzig and University Hospital Leipzig, Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum Munich , Leipzig , Germany
| | - B Sheikh
- University of Leipzig and University Hospital Leipzig, Helmholtz Institute for Metabolic, Obesity and Vascular Research of the Helmholtz Zentrum Munich , Leipzig , Germany
| | - M Blueher
- University of Leipzig Medical Center , Leipzig , Germany
| | - A Kogel
- University Hospital Leipzig , Leipzig , Germany
| | - M Scholz
- University of Leipzig , Leipzig , Germany
| | - K Miehle
- University of Leipzig Medical Center , Leipzig , Germany
| | - T Ebert
- University of Leipzig Medical Center , Leipzig , Germany
| | - U Laufs
- University Hospital Leipzig , Leipzig , Germany
| | - A Toenjes
- University of Leipzig Medical Center , Leipzig , Germany
| | - J N Boeckel
- University Hospital Leipzig , Leipzig , Germany
| |
Collapse
|
6
|
Iliakis G, Mladenov E, Mladenova V, Soni A, Stuschke M, Scholz M. SP-0841 DSB complexity: A key to cell lethality. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)04036-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Marciniak Ł, Akel M, Kulińska A, Lee S, Scholz M, Saw S. Results of plasma radiative compression investigation in the PF-24 device operated with D2, Ar and (100%-x)D2+x%Ar mixtures obtained using the 5-phase Lee model code. Appl Radiat Isot 2022; 182:110118. [DOI: 10.1016/j.apradiso.2022.110118] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2021] [Revised: 01/18/2022] [Accepted: 01/18/2022] [Indexed: 11/25/2022]
|
8
|
Petrov I, Boesenberg U, Bushuev VA, Hallmann J, Kazarian K, Lu W, Möller J, Reiser M, Rodriguez-Fernandez A, Samoylova L, Scholz M, Sinn H, Zozulya A, Madsen A. Performance of a cryo-cooled crystal monochromator illuminated by hard X-rays with MHz repetition rate at the European X-ray Free-Electron Laser. Opt Express 2022; 30:4978-4987. [PMID: 35209469 DOI: 10.1364/oe.451110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 01/18/2022] [Indexed: 06/14/2023]
Abstract
Due to the high intensity and MHz repetition rate of photon pulses generated by the European X-ray Free-Electron Laser, the heat load on silicon crystal monochromators can become large and prevent ideal transmission in Bragg diffraction geometry due to crystal deformation. Here, we present experimental data illustrating how heat load affects the performance of a cryogenically cooled monochromator under such conditions. The measurements are in good agreement with a depth-uniform model of X-ray dynamical diffraction taking beam absorption and heat deformation of the crystals into account.
Collapse
|
9
|
Lucaciu R, Suchorska B, Wettig M, Jung S, Scholz M. P04.22 Tumor treating fields in high-grade glioma patients: A retrospective single-center study. Neuro Oncol 2021. [DOI: 10.1093/neuonc/noab180.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
Tumor-treating fields (TTFields) are a modern anti-mitotic, non-invasive therapy for the treatment of patients with recurrent and newly diagnosed glioblastoma multiforme (GBM). In Europe, Optune® recieved in 2015 the CE certification. TTFields are a low-intensity (1–3 V/cm) approved therapeutic modality using a non-invasive application of intermediate frequency (200 kHz) alternating electric fields through four transducer arrays directly applied to the skin. The EF-14 study has shown that the addition of TTFields to temozolomide chemotherapy in patients with newly diagnosed GBM significantly improved overall survival (OS) and progression-free survival (PFS) without additional adverse events, apart from mild to moderate skin irritations (Stupp et al., JAMA 2017).
MATERIAL
We retrospectively analyzed data from TTFields-treated patients (2015–2020) that were treated at our department. Patient characteristics such as MGMT promoter methylation status, age, and diagnosis, as well as treatment duration and TTFields therapy usage, were evaluated for this study.
RESULTS
29 patients were treated with TTFields therapy between 2015 and 2020 at our hospital. Most patients received TTFields as primary treatment together with temozolomide maintenance therapy. In detail, 48% of patients were diagnosed with newly diagnosed GBM, 41% received TTFields therapy after tumor recurrence and 10% were diagnosed with other high-grade gliomas. In summary, patients could integrate TTFields therapy into their daily life and showed high adherence to the therapy.Particularly, one of our patients (with MGMT-promoter methylation positive) receives TTFields therapy now for almost 1229 days (approx. 41 months) and is still on therapy. Additionally, this patient shows a high usage rate of 86% indicating well integration of the therapy into daily life.
CONCLUSION
Taken together, our data provided the outcomes of using TTFields together with chemotherapy in the treatment of recurrent and newly diagnosed GBM in our department. Therapy with TTFields has been showing to provide significant clinical benefit for GBM patients.
Collapse
Affiliation(s)
- R Lucaciu
- Sana Hospital Duisburg, Duisburg, Germany
| | | | - M Wettig
- Sana Hospital Duisburg, Duisburg, Germany
| | - S Jung
- Sana Hospital Duisburg, Duisburg, Germany
| | - M Scholz
- Sana Hospital Duisburg, Duisburg, Germany
| |
Collapse
|
10
|
Bracher J, Wolffram D, Deuschel J, Görgen K, Ketterer JL, Ullrich A, Abbott S, Barbarossa MV, Bertsimas D, Bhatia S, Bodych M, Bosse NI, Burgard JP, Castro L, Fairchild G, Fuhrmann J, Funk S, Gogolewski K, Gu Q, Heyder S, Hotz T, Kheifetz Y, Kirsten H, Krueger T, Krymova E, Li ML, Meinke JH, Michaud IJ, Niedzielewski K, Ożański T, Rakowski F, Scholz M, Soni S, Srivastava A, Zieliński J, Zou D, Gneiting T, Schienle M. A pre-registered short-term forecasting study of COVID-19 in Germany and Poland during the second wave. Nat Commun 2021; 12:5173. [PMID: 34453047 PMCID: PMC8397791 DOI: 10.1038/s41467-021-25207-0] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2020] [Accepted: 07/28/2021] [Indexed: 12/31/2022] Open
Abstract
Disease modelling has had considerable policy impact during the ongoing COVID-19 pandemic, and it is increasingly acknowledged that combining multiple models can improve the reliability of outputs. Here we report insights from ten weeks of collaborative short-term forecasting of COVID-19 in Germany and Poland (12 October-19 December 2020). The study period covers the onset of the second wave in both countries, with tightening non-pharmaceutical interventions (NPIs) and subsequently a decay (Poland) or plateau and renewed increase (Germany) in reported cases. Thirteen independent teams provided probabilistic real-time forecasts of COVID-19 cases and deaths. These were reported for lead times of one to four weeks, with evaluation focused on one- and two-week horizons, which are less affected by changing NPIs. Heterogeneity between forecasts was considerable both in terms of point predictions and forecast spread. Ensemble forecasts showed good relative performance, in particular in terms of coverage, but did not clearly dominate single-model predictions. The study was preregistered and will be followed up in future phases of the pandemic.
Collapse
Affiliation(s)
- J Bracher
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
- Computational Statistics Group, Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany.
| | - D Wolffram
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
- Computational Statistics Group, Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany
| | - J Deuschel
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | - K Görgen
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | - J L Ketterer
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | - A Ullrich
- Robert Koch Institute (RKI), Berlin, Germany
| | - S Abbott
- London School of Hygiene and Tropical Medicine, London, UK
| | - M V Barbarossa
- Frankfurt Institute for Advanced Studies, Frankfurt, Germany
| | - D Bertsimas
- Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - S Bhatia
- MRC Centre for Global Infectious Disease Analysis, Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), Imperial College London, London, UK
| | - M Bodych
- Wroclaw University of Science and Technology, Wroclaw, Poland
| | - N I Bosse
- London School of Hygiene and Tropical Medicine, London, UK
| | - J P Burgard
- Economic and Social Statistics Department, University of Trier, Trier, Germany
| | - L Castro
- Information Systems and Modeling, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - G Fairchild
- Information Systems and Modeling, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - J Fuhrmann
- Frankfurt Institute for Advanced Studies, Frankfurt, Germany
- Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - S Funk
- London School of Hygiene and Tropical Medicine, London, UK
| | - K Gogolewski
- Institute of Informatics, University of Warsaw, Warsaw, Poland
| | - Q Gu
- Department of Computer Science, University of California, Los Angeles, CA, USA
| | - S Heyder
- Institute of Mathematics, Technische Universität Ilmenau, Ilmenau, Germany
| | - T Hotz
- Institute of Mathematics, Technische Universität Ilmenau, Ilmenau, Germany
| | - Y Kheifetz
- Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
| | - H Kirsten
- Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
| | - T Krueger
- Wroclaw University of Science and Technology, Wroclaw, Poland
| | - E Krymova
- Swiss Data Science Center, ETH Zurich and EPFL, Lausanne, Switzerland
| | - M L Li
- Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - J H Meinke
- Jülich Supercomputing Centre, Forschungszentrum Jülich, Jülich, Germany
| | - I J Michaud
- Statistical Sciences Group, Los Alamos National Laboratory, Los Alamos, NM, USA
| | - K Niedzielewski
- Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw, Warsaw, Poland
| | - T Ożański
- Wroclaw University of Science and Technology, Wroclaw, Poland
| | - F Rakowski
- Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw, Warsaw, Poland
| | - M Scholz
- Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
| | - S Soni
- Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - A Srivastava
- Ming Hsieh Department of Computer and Electrical Engineering, University of Southern California, Los Angeles, CA, USA
| | - J Zieliński
- Interdisciplinary Centre for Mathematical and Computational Modeling, University of Warsaw, Warsaw, Poland
| | - D Zou
- Department of Computer Science, University of California, Los Angeles, CA, USA
| | - T Gneiting
- Computational Statistics Group, Heidelberg Institute for Theoretical Studies (HITS), Heidelberg, Germany
- Institute for Stochastics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
| | - M Schienle
- Chair of Statistics and Econometrics, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
| |
Collapse
|
11
|
Vondracek P, Panek R, Hron M, Havlicek J, Weinzettl V, Todd T, Tskhakaya D, Cunningham G, Hacek P, Hromadka J, Junek P, Krbec J, Patel N, Sestak D, Varju J, Adamek J, Balazsova M, Balner V, Barton P, Bielecki J, Bilkova P, Błocki J, Bocian D, Bogar K, Bogar O, Boocz P, Borodkina I, Brooks A, Bohm P, Burant J, Casolari A, Cavalier J, Chappuis P, Dejarnac R, Dimitrova M, Dudak M, Duran I, Ellis R, Entler S, Fang J, Farnik M, Ficker O, Fridrich D, Fukova S, Gerardin J, Hanak I, Havranek A, Herrmann A, Horacek J, Hronova O, Imrisek M, Isernia N, Jaulmes F, Jerab M, Kindl V, Komm M, Kovarik K, Kral M, Kripner L, Macusova E, Majer T, Markovic T, Matveeva E, Mikszuta-Michalik K, Mohelnik M, Mysiura I, Naydenkova D, Nemec I, Ortwein R, Patocka K, Peterka M, Podolnik A, Prochazka F, Prevratil J, Reboun J, Scalera V, Scholz M, Svoboda J, Swierblewski J, Sos M, Tadros M, Titus P, Tomes M, Torres A, Tracz G, Turjanica P, Varavin M, Veselovsky V, Villone F, Wąchal P, Yanovskiy V, Zadvitskiy G, Zajac J, Zak A, Zaloga D, Zelda J, Zhang H. Preliminary design of the COMPASS upgrade tokamak. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112490] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Bertoglio F, Fühner V, Ruschig M, Heine PA, Abassi L, Klünemann T, Rand U, Meier D, Langreder N, Steinke S, Ballmann R, Schneider KT, Roth KDR, Kuhn P, Riese P, Schäckermann D, Korn J, Koch A, Chaudhry MZ, Eschke K, Kim Y, Zock-Emmenthal S, Becker M, Scholz M, Moreira GMSG, Wenzel EV, Russo G, Garritsen HSP, Casu S, Gerstner A, Roth G, Adler J, Trimpert J, Hermann A, Schirrmann T, Dübel S, Frenzel A, Van den Heuvel J, Čičin-Šain L, Schubert M, Hust M. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations. Cell Rep 2021; 36:109433. [PMID: 34273271 PMCID: PMC8260561 DOI: 10.1016/j.celrep.2021.109433] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2020] [Revised: 05/20/2021] [Accepted: 06/30/2021] [Indexed: 12/11/2022] Open
Abstract
The novel betacoronavirus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) causes a form of severe pneumonia disease called coronavirus disease 2019 (COVID-19). To develop human neutralizing anti-SARS-CoV-2 antibodies, antibody gene libraries from convalescent COVID-19 patients were constructed and recombinant antibody fragments (scFv) against the receptor-binding domain (RBD) of the spike protein were selected by phage display. The antibody STE90-C11 shows a subnanometer IC50 in a plaque-based live SARS-CoV-2 neutralization assay. The in vivo efficacy of the antibody is demonstrated in the Syrian hamster and in the human angiotensin-converting enzyme 2 (hACE2) mice model. The crystal structure of STE90-C11 Fab in complex with SARS-CoV-2-RBD is solved at 2.0 Å resolution showing that the antibody binds at the same region as ACE2 to RBD. The binding and inhibition of STE90-C11 is not blocked by many known emerging RBD mutations. STE90-C11-derived human IgG1 with FcγR-silenced Fc (COR-101) is undergoing Phase Ib/II clinical trials for the treatment of moderate to severe COVID-19.
Collapse
Affiliation(s)
- Federico Bertoglio
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Viola Fühner
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Maximilian Ruschig
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Philip Alexander Heine
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Leila Abassi
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Thomas Klünemann
- Helmholtz Centre for Infection Research, Department of Structure and Function of Proteins, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Ulfert Rand
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Doris Meier
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Nora Langreder
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Stephan Steinke
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Rico Ballmann
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Kai-Thomas Schneider
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Kristian Daniel Ralph Roth
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Philipp Kuhn
- YUMAB GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Peggy Riese
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany; Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Dorina Schäckermann
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Janin Korn
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Allan Koch
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - M Zeeshan Chaudhry
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Kathrin Eschke
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Yeonsu Kim
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Susanne Zock-Emmenthal
- Technische Universität Braunschweig, Institut für Genetik, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Marlies Becker
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Margitta Scholz
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Gustavo Marçal Schmidt Garcia Moreira
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Esther Veronika Wenzel
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Giulio Russo
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Hendrikus S P Garritsen
- Städtisches Klinikum Braunschweig gGmbH, Celler Str. 38, 38114 Braunschweig, Germany; Fraunhofer Institute for Surface Engineering and Thin Films IST, Bienroder Weg 54E, 38108 Braunschweig, Germany
| | - Sebastian Casu
- Helios Klinikum Salzgitter, Kattowitzer Str. 191, 38226 Salzgitter, Germany
| | - Andreas Gerstner
- Städtisches Klinikum Braunschweig gGmbH, Holwedestraße 16, 38118 Braunschweig, Germany
| | - Günter Roth
- BioCopy GmbH, Elzstrasse 27, 79312 Emmendingen, Germany
| | - Julia Adler
- Institute of Virology, Freie Universität Berlin, 14163 Berlin, Germany
| | - Jakob Trimpert
- Institute of Virology, Freie Universität Berlin, 14163 Berlin, Germany
| | - Andreas Hermann
- CORAT Therapeutics GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Thomas Schirrmann
- YUMAB GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany; CORAT Therapeutics GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Stefan Dübel
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - André Frenzel
- YUMAB GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany; Institute of Virology, Freie Universität Berlin, 14163 Berlin, Germany
| | - Joop Van den Heuvel
- Helmholtz Centre for Infection Research, Department of Structure and Function of Proteins, Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Luka Čičin-Šain
- Helmholtz Centre for Infection Research, Department of Vaccinology and Applied Microbiology, Inhoffenstr. 7, 38124 Braunschweig, Germany; Centre for Individualised Infection Medicine (CIIM), a joint venture of Helmholtz Centre for Infection Research and Medical School, Hannover, Germany
| | - Maren Schubert
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany
| | - Michael Hust
- Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Abteilung Biotechnologie, Spielmannstr. 7, 38106 Braunschweig, Germany.
| |
Collapse
|
13
|
Vassholz M, Hoeppe HP, Hagemann J, Rosselló JM, Osterhoff M, Mettin R, Kurz T, Schropp A, Seiboth F, Schroer CG, Scholz M, Möller J, Hallmann J, Boesenberg U, Kim C, Zozulya A, Lu W, Shayduk R, Schaffer R, Madsen A, Salditt T. Pump-probe X-ray holographic imaging of laser-induced cavitation bubbles with femtosecond FEL pulses. Nat Commun 2021; 12:3468. [PMID: 34103498 PMCID: PMC8187368 DOI: 10.1038/s41467-021-23664-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2020] [Accepted: 04/27/2021] [Indexed: 11/24/2022] Open
Abstract
Cavitation bubbles can be seeded from a plasma following optical breakdown, by focusing an intense laser in water. The fast dynamics are associated with extreme states of gas and liquid, especially in the nascent state. This offers a unique setting to probe water and water vapor far-from equilibrium. However, current optical techniques cannot quantify these early states due to contrast and resolution limitations. X-ray holography with single X-ray free-electron laser pulses has now enabled a quasi-instantaneous high resolution structural probe with contrast proportional to the electron density of the object. In this work, we demonstrate cone-beam holographic flash imaging of laser-induced cavitation bubbles in water with nanofocused X-ray free-electron laser pulses. We quantify the spatial and temporal pressure distribution of the shockwave surrounding the expanding cavitation bubble at time delays shortly after seeding and compare the results to numerical simulations.
Collapse
Affiliation(s)
- M Vassholz
- Institut für Röntgenphysik, Georg-August-Universität Göttingen, Göttingen, Germany
| | - H P Hoeppe
- Institut für Röntgenphysik, Georg-August-Universität Göttingen, Göttingen, Germany
| | - J Hagemann
- CXNS - Center for X-ray and Nano Science, Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J M Rosselló
- Drittes Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - M Osterhoff
- Institut für Röntgenphysik, Georg-August-Universität Göttingen, Göttingen, Germany
| | - R Mettin
- Drittes Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - T Kurz
- Drittes Physikalisches Institut, Georg-August-Universität Göttingen, Göttingen, Germany
| | - A Schropp
- CXNS - Center for X-ray and Nano Science, Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - F Seiboth
- CXNS - Center for X-ray and Nano Science, Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - C G Schroer
- CXNS - Center for X-ray and Nano Science, Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
- Department Physik, Universität Hamburg, Hamburg, Germany
| | - M Scholz
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - J Möller
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - J Hallmann
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - U Boesenberg
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - C Kim
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - A Zozulya
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - W Lu
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - R Shayduk
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - R Schaffer
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - A Madsen
- European X-Ray Free-Electron Laser Facility, Schenefeld, Germany
| | - T Salditt
- Institut für Röntgenphysik, Georg-August-Universität Göttingen, Göttingen, Germany.
| |
Collapse
|
14
|
Madsen A, Hallmann J, Ansaldi G, Roth T, Lu W, Kim C, Boesenberg U, Zozulya A, Möller J, Shayduk R, Scholz M, Bartmann A, Schmidt A, Lobato I, Sukharnikov K, Reiser M, Kazarian K, Petrov I. Materials Imaging and Dynamics (MID) instrument at the European X-ray Free-Electron Laser Facility. J Synchrotron Radiat 2021; 28:637-649. [PMID: 33650576 PMCID: PMC7941285 DOI: 10.1107/s1600577521001302] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Accepted: 02/04/2021] [Indexed: 05/27/2023]
Abstract
The Materials Imaging and Dynamics (MID) instrument at the European X-ray Free-Electron Laser (EuXFEL) facility is described. EuXFEL is the first hard X-ray free-electron laser operating in the MHz repetition range which provides novel science opportunities. The aim of MID is to enable studies of nano-structured materials, liquids, and soft- and hard-condensed matter using the bright X-ray beams generated by EuXFEL. Particular emphasis is on studies of structure and dynamics in materials by coherent scattering and imaging using hard X-rays. Commission of MID started at the end of 2018 and first experiments were performed in 2019.
Collapse
Affiliation(s)
- A. Madsen
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - J. Hallmann
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - G. Ansaldi
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - T. Roth
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - W. Lu
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - C. Kim
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - U. Boesenberg
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A. Zozulya
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - J. Möller
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - R. Shayduk
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - M. Scholz
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A. Bartmann
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - A. Schmidt
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - I. Lobato
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - K. Sukharnikov
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - M. Reiser
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - K. Kazarian
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| | - I. Petrov
- European X-ray Free-Electron Laser Facility, Holzkoppel 4, 22869 Schenefeld, Germany
| |
Collapse
|
15
|
Scholz M, Onal B, Schleicher P, Pingel A, Hoffmann C, Kandziora F. Two-level ACDF with a zero-profile stand-alone spacer compared to conventional plating: a prospective randomized single-center study. Eur Spine J 2020; 29:2814-2822. [PMID: 32430769 DOI: 10.1007/s00586-020-06454-z] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/08/2020] [Accepted: 05/06/2020] [Indexed: 10/24/2022]
Abstract
PURPOSE Stand-alone zero-profile devices have already proven safety, and a reduced dysphagia rate was assumed. So far, no level-one evidence is available to prove the proposed advantages of zero-profile implants in multilevel procedures. The aim of this RCT was to compare the clinical and radiological outcome of a zero-profile spacer versus cage + plate in two-level ACDF. METHODS Consecutive patients with contiguous two-level cDD were randomly assigned either to the interventional group (zero-profile device) or to the control group (cage + plate). Primary endpoint of the study was the prevalence of dysphagia at 24 months. Disability, progress of adjacent segment degeneration, fusion status and loss of correction were analyzed as secondary outcome measure. Primary outcome parameter was statistically analyzed by Chi-square test. RESULTS Forty-one patients met inclusion criteria and were randomly assigned to the interventional and the control group. Dysphagia was frequent in either group at 3 months FU favoring interventional group (p = 0.078). At final FU, less patients of the interventional group complained about dysphagia, but the difference was not significant. No relevant differences at final FU were recorded for NPDI, loss of correction and adjacent-level degeneration. Fusion rate was slightly lower in the interventional group. DISCUSSION Two-level ACDF either by a stand-alone zero-profile spacer or cage + plate is safe. Using a zero-profile cage dysphagia was infrequent at 24 months, but the value did not reach statistical significance in comparison with the cage + plate. Hence, this randomized trial was not able to prove the proposed clinical superiority for dysphagia rates for zero-profile anchored spacer in two-level cDD.
Collapse
Affiliation(s)
- M Scholz
- Center for Spinal Surgery and Neurotraumatology, BG Unfallklinik Frankfurt am Main gGmbH, Friedberger Landstraße 430, 60389, Frankfurt am Main, Germany.
| | - B Onal
- Neurosurgical Department, Acıbadem University Vocational School of Health Services, Istanbul, Turkey
| | - P Schleicher
- Center for Spinal Surgery and Neurotraumatology, BG Unfallklinik Frankfurt am Main gGmbH, Friedberger Landstraße 430, 60389, Frankfurt am Main, Germany
| | - A Pingel
- Center for Spinal Surgery and Neurotraumatology, BG Unfallklinik Frankfurt am Main gGmbH, Friedberger Landstraße 430, 60389, Frankfurt am Main, Germany
| | - C Hoffmann
- Center for Spinal Surgery and Neurotraumatology, BG Unfallklinik Frankfurt am Main gGmbH, Friedberger Landstraße 430, 60389, Frankfurt am Main, Germany
| | - F Kandziora
- Center for Spinal Surgery and Neurotraumatology, BG Unfallklinik Frankfurt am Main gGmbH, Friedberger Landstraße 430, 60389, Frankfurt am Main, Germany
| |
Collapse
|
16
|
Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19? Med Hypotheses 2020; 142:109815. [PMID: 32408070 PMCID: PMC7202847 DOI: 10.1016/j.mehy.2020.109815] [Citation(s) in RCA: 109] [Impact Index Per Article: 27.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2020] [Revised: 04/24/2020] [Accepted: 05/05/2020] [Indexed: 12/27/2022]
Abstract
Currently, drug repurposing is an alternative to novel drug development for the treatment of COVID-19 patients. The antimalarial drug chloroquine (CQ) and its metabolite hydroxychloroquine (HCQ) are currently being tested in several clinical studies as potential candidates to limit SARS-CoV-2-mediated morbidity and mortality. CQ and HCQ (CQ/HCQ) inhibit pH-dependent steps of SARS-CoV-2 replication by increasing pH in intracellular vesicles and interfere with virus particle delivery into host cells. Besides direct antiviral effects, CQ/HCQ specifically target extracellular zinc to intracellular lysosomes where it interferes with RNA-dependent RNA polymerase activity and coronavirus replication. As zinc deficiency frequently occurs in elderly patients and in those with cardiovascular disease, chronic pulmonary disease, or diabetes, we hypothesize that CQ/HCQ plus zinc supplementation may be more effective in reducing COVID-19 morbidity and mortality than CQ or HCQ in monotherapy. Therefore, CQ/HCQ in combination with zinc should be considered as additional study arm for COVID-19 clinical trials.
Collapse
Affiliation(s)
- R Derwand
- Alexion Pharma Germany GmbH, Landsberger Str. 300, 80687 Munich, Germany
| | - M Scholz
- LEUKOCARE AG, Am Klopferspitz 19, Martinsried, Munich, Germany.
| |
Collapse
|
17
|
Berndtsson R, Becker P, Persson A, Aspegren H, Haghighatafshar S, Jönsson K, Larsson R, Mobini S, Mottaghi M, Nilsson J, Nordström J, Pilesjö P, Scholz M, Sternudd C, Sörensen J, Tussupova K. Drivers of changing urban flood risk: A framework for action. J Environ Manage 2019; 240:47-56. [PMID: 30928794 DOI: 10.1016/j.jenvman.2019.03.094] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Revised: 03/12/2019] [Accepted: 03/19/2019] [Indexed: 06/09/2023]
Abstract
This study focuses on drivers for changing urban flood risk. We suggest a framework for guiding climate change adaptation action concerning flood risk and manageability in cities. The identified key drivers of changing flood hazard and vulnerability are used to provide an overview of each driver's impact on flood risk and manageability at the city level. We find that identified drivers for urban flood risk can be grouped in three different priority areas with different time horizon. The first group has high impact but is manageable at city level. Typical drivers in this group are related to the physical environment such as decreasing permeability and unresponsive engineering. The second group of drivers is represented by public awareness and individual willingness to participate and urbanization and urban sprawl. These drivers may be important and are manageable for the cities and they involve both short-term and long-term measures. The third group of drivers is related to policy and long-term changes. This group is represented by economic growth and increasing values at risk, climate change, and increasing complexity of society. They have all high impact but low manageability. Managing these drivers needs to be done in a longer time perspective, e.g., by developing long-term policies and exchange of ideas.
Collapse
Affiliation(s)
- R Berndtsson
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden; Center for Middle Eastern Studies, Lund University, SE-221 00, Lund, Sweden.
| | - P Becker
- Risk Management and Societal Safety, Lund University, SE-221 00, Lund, Sweden; Unit for Environmental Sciences and Management, North-West University, Potchefstroom, 2520, South Africa
| | - A Persson
- GIS Centre/Physical Geography and Ecosystem Science, Lund University, SE-221 00, Lund, Sweden
| | - H Aspegren
- Water and Environmental Engineering, Lund University, SE-221 00, Lund, Sweden; VA SYD, SE-211 20 Malmö, Sweden
| | - S Haghighatafshar
- Water and Environmental Engineering, Lund University, SE-221 00, Lund, Sweden
| | - K Jönsson
- Water and Environmental Engineering, Lund University, SE-221 00, Lund, Sweden
| | - R Larsson
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden
| | - S Mobini
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden
| | - M Mottaghi
- Water and Environmental Engineering, Lund University, SE-221 00, Lund, Sweden; VA SYD, SE-211 20 Malmö, Sweden; Architecture and Built Environment, Lund University, SE-221 00, Lund, Sweden
| | - J Nilsson
- Faculty of Culture and Society, Malmö University, SE-205 06, Malmö, Sweden
| | - J Nordström
- AgriFood, Economics Centre, Lund University, SE-220 07, Lund, Sweden
| | - P Pilesjö
- Center for Middle Eastern Studies, Lund University, SE-221 00, Lund, Sweden; GIS Centre/Physical Geography and Ecosystem Science, Lund University, SE-221 00, Lund, Sweden
| | - M Scholz
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden; Department of Civil Engineering Science, University of Johannesburg, PO Box 524, Johannesburg, South Africa; Directorate of Civil Engineering, University of Salford, Greater Manchester, M5 4WT, United Kingdom
| | - C Sternudd
- Architecture and Built Environment, Lund University, SE-221 00, Lund, Sweden
| | - J Sörensen
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden
| | - K Tussupova
- Water Resources Engineering, Lund University, SE-221 00, Lund, Sweden; Center for Middle Eastern Studies, Lund University, SE-221 00, Lund, Sweden; Center for Transfer of Technology, Karaganda State Medical University, 100004, Karaganda, Kazakhstan
| |
Collapse
|
18
|
Schneider H, Steigerwald-Otremba AS, Häfer M, Krause F, Scholz M, Haak R. Is Optical Coherence Tomography a Potential Tool to Evaluate Marginal Adaptation of Class III/IV Composite Restorations In Vivo? Oper Dent 2018; 44:242-253. [PMID: 30517066 DOI: 10.2341/17-192-c] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE Margin analysis of Class III and IV composite restorations in vitro and in vivo occurred by scanning electron microscopy (SEM) and optical coherence tomography (OCT). The results were compared and related to clinical evaluation. METHODS AND MATERIALS Eight Class III composite restorations were imaged in vitro using OCT and SEM. The margins were analyzed quantitatively. OCT signals were verified by assignment to the criteria perfect margin, gap, and positive/negative ledge. In vivo quantitative margin analysis of Class III/IV composite restorations made of the micro-hybrid composite Venus combined with the self-etch adhesive iBond Gluma inside (1-SE) or etch-and-rinse adhesive Gluma Comfort Bond (2-ER) (all Heraeus Kulzer) was carried out using OCT and SEM after 90 months of clinical function. The results were compared with clinical evaluation (US Public Health Service criteria; marginal integrity, marginal discoloration). RESULTS In vitro, the correlation between OCT and SEM was high for all four margin criteria (Kendall tau b [τb] correlation: 0.64-0.92, pi≤0.026), with no significant differences between OCT and SEM (pi≥0.63). In vivo, a moderate correlation was observed (τb: 0.38-0.45, pi<0.016). Clinically, the cumulative failure rate in the criterion marginal integrity was higher for the 1-SE group (baseline 90 M, p=0.011). Similarly, OCT and SEM detected higher percentages of the criterion gap in the 1-SE group (p: 0.027/0.002), in contrast to perfect margin. Both, gap and perfect margin ranged widely between 0.0% and 88.7% (OCT) and between 0.0% and 89.0% (SEM). CONCLUSION Despite the positive selection bias after 90 months with only a few patients left, quantitative margin analysis allows for differentiation between the two adhesives at this specific date. OCT in particular offers the possibility to evaluate marginal integrity directly in vivo.
Collapse
|
19
|
Wójcik-Gargula A, Tracz G, Scholz M. CALCULATIONS OF SHUTDOWN DOSE RATE FOR THE TPR SPECTROMETER OF THE HIGH-RESOLUTION NEUTRON SPECTROMETER FOR ITER. Radiat Prot Dosimetry 2018; 180:75-79. [PMID: 29244166 DOI: 10.1093/rpd/ncx270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2017] [Accepted: 11/17/2017] [Indexed: 06/07/2023]
Abstract
This work presents results of the calculations performed in order to predict the neutron-induced activity in structural materials that are considered to be using at the TPR spectrometer-one of the detection system of the High-Resolution Neutron Spectrometer for ITER. An attempt has been made to estimate the shutdown dose rates in a Cuboid #1 and to check if they satisfy ICRP regulatory requirements for occupational exposure to radiation and ITER nuclear safety regulations for areas with personal access. The results were obtained by the MCNP and FISPACT-II calculations.
Collapse
Affiliation(s)
- A Wójcik-Gargula
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - G Tracz
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - M Scholz
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| |
Collapse
|
20
|
Bielecki J, Drozdowicz K, Dworak D, Igielski A, Janik W, Kulinska A, Marciniak L, Scholz M, Turzanski M, Wiacek U, Woznicka U, Wójcik-Gargula A. EXPERIMENTAL AND MONTE CARLO INVESTIGATIONS OF BCF-12 SMALL‑AREA PLASTIC SCINTILLATION DETECTORS FOR NEUTRON PINHOLE CAMERA. Radiat Prot Dosimetry 2018; 180:427-431. [PMID: 29237067 DOI: 10.1093/rpd/ncx277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Plastic organic scintillators such as the blue-emitting BCF-12 are versatile and inexpensive tools. Recently, BCF-12 scintillators have been foreseen for investigation of the spatial distribution of neutrons emitted from dense magnetized plasma. For this purpose, small-area (5 mm × 5 mm) detectors based on BCF-12 scintillation rods and Hamamatsu photomultiplier tubes were designed and constructed at the Institute of Nuclear Physics. They will be located inside the neutron pinhole camera of the PF-24 plasma focus device. Two different geometrical layouts and approaches to the construction of the scintillation element were tested. The aim of this work was to determine the efficiency of the detectors. For this purpose, the experimental investigations using a neutron generator and a Pu-Be source were combined with Monte Carlo computations using the Geant4 code.
Collapse
Affiliation(s)
- J Bielecki
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - K Drozdowicz
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - D Dworak
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - A Igielski
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - W Janik
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - A Kulinska
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - L Marciniak
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - M Scholz
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - M Turzanski
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - U Wiacek
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - U Woznicka
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| | - A Wójcik-Gargula
- Institute of Nuclear Physics Polish Academy of Sciences (IFJ PAN), Krakow, Poland
| |
Collapse
|
21
|
Lalem T, Zhang L, Scholz M, Burkhardt R, Saccheti V, Thiery J, Devaux Y. P830Cyclin dependent kinase inhibitor 1C (CDKN1C), a novel female-specific marker of left ventricular dysfunction after acute myocardial infarction. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.p830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- T Lalem
- Luxembourg Institute of Health, CVRU, Strassen, Luxembourg
| | - L Zhang
- Luxembourg Institute of Health, CVRU, Strassen, Luxembourg
| | - M Scholz
- University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany
| | - R Burkhardt
- Leipzig University Hospital, Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Leipzig, Germany
| | - V Saccheti
- Luxembourg Institute of Health, CVRU, Strassen, Luxembourg
| | - J Thiery
- Heart Center of Leipzig, Leipzig, Germany
| | - Y Devaux
- Luxembourg Institute of Health, CVRU, Strassen, Luxembourg
| | | |
Collapse
|
22
|
Jacobi T, Scheffler L, Scholz M, Schuch A, Stumvoll M, Tönjes A, Klöting N, Blüher M, Kovacs P. Protektiv- und Risiko-HLA Allele für Typ 2 Diabetes Mellitus in 3 deutschen Kohorten. DIABETOL STOFFWECHS 2018. [DOI: 10.1055/s-0038-1657796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- T Jacobi
- Universitätsmedizin Leipzig, IFB AdipositasErkrankungen, Leipzig, Germany
| | - L Scheffler
- Universitätsmedizin Leipzig, IFB AdipositasErkrankungen, Leipzig, Germany
| | - M Scholz
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig, Germany
| | - A Schuch
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig, Germany
| | - M Stumvoll
- Universitätsklinikum Leipzig, Klinik für Endokrinologie und Nephrologie, Leipzig, Germany
| | - A Tönjes
- Universitätsklinikum Leipzig, Klinik für Endokrinologie und Nephrologie, Leipzig, Germany
| | - N Klöting
- Universitätsmedizin Leipzig, IFB AdipositasErkrankungen, Leipzig, Germany
| | - M Blüher
- Universitätsmedizin Leipzig, IFB AdipositasErkrankungen, Leipzig, Germany
| | - P Kovacs
- Universitätsmedizin Leipzig, IFB AdipositasErkrankungen, Leipzig, Germany
| |
Collapse
|
23
|
Marciniak Ł, Akel M, Kulińska A, Scholz M, Lee S, Kunze HJ, Saw SH. Measurements and Simulations of Neutron Emission Versus Deuterium Filling Pressure in Plasma Focus Device PF-24. J Fusion Energ 2018. [DOI: 10.1007/s10894-018-0157-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
24
|
Abstract
BACKGROUND In Germany, currently two out of three medical students are female. Several studies corroborate that medical students show a significantly higher prevalence of stress-related mental disorders than the population in general. AIMS We aimed to evaluate, if gender has an influence on the distribution of mental stress parameters and learning style among male and female medical students. METHODS We investigated a total of 758 students of the medical faculty at the University of Erlangen-Nuernberg, Germany, using standardized and validated psychological questionnaires on depressive symptoms (BDI-II), burnout (BOSS-II) and quality of life (SF-12). In addition, we screened the students for their learning styles according to Kolb. RESULTS Out of 723 participants who declared their gender, 57.8% were female and 37.6% were male. Female students showed significantly higher values for depressiveness as well as for emotional and cognitive burnout, whereas the mental quality of life was significantly lower. A considerably higher percentage of male students with a converging or an accommodating learning style were found in comparison to their female fellows. CONCLUSIONS We postulate that an adaptation of the medical curriculum content to the investigated factors may contribute to a higher mental stability and less stress-related symptoms in medical students.
Collapse
Affiliation(s)
- P H M Burger
- Hospital Meissenberg, Psychiatric and Psychotherapeutical Specialist Hospital for Women, Zug, Switzerland
| | - M Scholz
- Department of Anatomy II, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
| |
Collapse
|
25
|
Ahnert P, Creutz P, Schwarzenberger F, Kiehntopf M, Bauer M, Völker U, Chakraborty T, Löffler M, Suttorp N, Scholz M. Sequential Organ Failure Assessment (SOFA) Score as Operationalization of Disease Severity of hospitalized Community acquired Pneumonia (CAP). Pneumologie 2018. [DOI: 10.1055/s-0037-1619377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- P Ahnert
- Institut für Medizinische Informatik, Statistik und Epidemiologie, Mediziniche Fakultät, Universität Leipzig
| | - P Creutz
- Department of Infectious Disease and Respiratory Medicine, Charité Universitätsmedizin Berlin
| | - F Schwarzenberger
- Faculty of Informatics/Mathematics, Dresden University of Applied Sciences
| | - M Kiehntopf
- Integrated Biobank Jena and Institute of Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital
| | - M Bauer
- Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital
| | - U Völker
- Interfaculty Institute of Genetics and Functional Genomics, University Medicine Greifswald
| | - T Chakraborty
- Institute for Medical Microbiology, University Hospital Gießen
| | - M Löffler
- Institut für Medizinische Informatik, Statistik und Epidemiologie, Mediziniche Fakultät, Universität Leipzig
| | - N Suttorp
- Department of Infectious Disease and Respiratory Medicine, Charité Universitätsmedizin Berlin
| | - M Scholz
- Institut für Medizinische Informatik, Statistik und Epidemiologie, Mediziniche Fakultät, Universität Leipzig
| |
Collapse
|
26
|
Bauer M, Kirsten H, Grunow E, Ahnert P, Kiehntopf M, Creutz P, Löffler M, Suttorp N, Scholz M. Gene expression patterns in blood predict future severe endpoints in community acquired pneumonia. Pneumologie 2018. [DOI: 10.1055/s-0037-1619138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Bauer
- Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
| | - H Kirsten
- Institut für Medizinische Informatik, Statistik und Epidemiologie (Imise), Universität Leipzig
| | | | - P Ahnert
- Institut für Medizinische Informatik, Statistik und Epidemiologie (Imise), Universität Leipzig
| | - M Kiehntopf
- Institut für Klinische Chemie und Laboratoriumsdiagnostik, Universitätsklinikum Jena
| | - P Creutz
- Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charité-Universitätsmedizin Berlin
| | - M Löffler
- Institut für Medizinische Informatik, Statistik und Epidemiologie (Imise), Universität Leipzig
| | - N Suttorp
- Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charité-Universitätsmedizin Berlin
| | - M Scholz
- Institut für Medizinische Informatik, Statistik und Epidemiologie (Imise), Universität Leipzig
| |
Collapse
|
27
|
Creutz P, Ahnert P, Kirsten H, Kiehntopf M, Bauer M, Völker U, Chakraborty T, Scholz M, Löffler M, Suttorp N. Prediction of 28 day mortality and need for ICU treatment in the PROGRESS Study by CAP severity scores. Pneumologie 2018. [DOI: 10.1055/s-0037-1619137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- P Creutz
- Med. Klinik mit Schwerpunkt Infektiologie und Pneumologie, Charité-Universitätsmedizin Berlin; Campus Benjamin Franklin
| | - P Ahnert
- Institut für Medizinische Informatik, Statistik und Epidemiologie, Mediziniche Fakultät, Universität Leipzig
| | - H Kirsten
- Institut für Medizinische Informatik, Statistik und Epidemiologie, Mediziniche Fakultät, Universität Leipzig
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Hasenclever D, Scholz M, Wehrend A, Schönfelder A. Rentabilitätsberechnung des Kaiserschnitts beim Schaf. Tierarztl Prax Ausg G Grosstiere Nutztiere 2018. [DOI: 10.1055/s-0037-1621527] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Zusammenfassung
Gegenstand: In der vorliegenden Studie wird eine Rentabilitätsberechnung zum Kaiserschnitt beim Schaf nach konservativ nicht korrigierbarer Schwergeburt erstellt. Material und Methode: Die Berechnungen stützen sich auf 119 durchgeführte Kaiserschnitte und das anschließende Schicksal der Mutterschafe und entwickelten Lämmer. Ergebnisse: Eine konservativ nicht korrigierbare Schwergeburt stellt für Schafhalter immer ein Verlustgeschäft dar. Werden die Tiere nicht behandelt, sondern euthanasiert, liegt der finanzielle Schaden bei 117,90 荤. Dieses Verlustgeschäft kann bei Tierhaltern mit mehr als 10 Mutterschafen durch eine Sectio caesarea um ca. 20% auf 95,08 荤 minimiert werden, weil diese Tierhalter mit der Mutterschaf-/ Grünlandprämie über eine zusätzliche Einnahmequelle pro Mutterschaf verfügen. Diese Berechung gilt nicht für Hobbyschafhalter mit weniger als 10 Mutterschafen, da hier die Einnahmen durch diese Prämien wegfallen. In diesen Fällen spielt jedoch meist nicht nur der ökonomische Aspekt für oder gegen die Operationsentscheidung eine Rolle. Schlussfolgerung: Die in dieser Studie dargestellten Berechnungen zeigen, dass der finanzielle Rahmen der Schafhaltung eng ist. Trotzdem stellt die Operation die ökonomisch überlegene Strategie gegenüber der Euthanasie dar, wenn Mutterschaf und Lämmer die Operation überleben. Mit 97,8%iger Wahrscheinlichkeit lohnt sich somit die operative Therapie.
Collapse
|
29
|
Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, Moustafa Z, Scholz M, Lisboa B, Mohrmann S, Möbus V, Augustin D, Hoffmann G, Weiss E, Böhmer S, Kreienberg R, Du Bois A, Sattler D, Thomssen C, Kiechle M, Jänicke F, Wallwiener D, Harbeck N, Kuhn W. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. Ann Oncol 2017; 28:2899. [PMID: 27634692 DOI: 10.1093/annonc/mdw349] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/08/2023] Open
Affiliation(s)
- U Nitz
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany.
| | - O Gluz
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - J Huober
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - H H Kreipe
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - R E Kates
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - A Hartmann
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - R Erber
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - Z Moustafa
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - M Scholz
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - B Lisboa
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - S Mohrmann
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - V Möbus
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - D Augustin
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - G Hoffmann
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - E Weiss
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - S Böhmer
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - R Kreienberg
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - A Du Bois
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - D Sattler
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - C Thomssen
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - M Kiechle
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - F Jänicke
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - D Wallwiener
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - N Harbeck
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| | - W Kuhn
- Women's Clinic, Heinrich-Heine-University Duesseldorf, Duesseldorf; West German Study Group, Moenchengladbach; Breast Center Niederrhein, Ev. Bethesda Hospital, Moenchengladbach; Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen; Institute of Pathology, Hannover Medical School, Hannover; Institute of Pathology, University Clinics Erlangen, Erlangen; Trium Analysis Online GmbH, Munich; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg; Department of Obstetrics and Gynecology, Staedtisches Klinikum, Frankfurt; Clinics Deggendorf Mammacenter Ostbayern, Deggendorf; Breast Center, St Josephs-Hospital, Wiesbaden; Women's Clinic, Kreiskrankenhaus Boeblingen, Boeblingen; Department of Obstetrics and Gynecology, Ev. Hospital Oberhausen, Oberhausen; Breast Center, University Women's Clinic Ulm, Ulm; Department of Gynecology and Oncology, Dr. Horst-Schmidt-Klinik GmbH, Wiesbaden; Department of Gynecology and Obstetrics, Klinikum Rechts der Isar der Technischen Universität Muenchen (TUM), Munich; Breast Center, Women's Clinic and CCCLMU of the University of Munich, Munich; Department of Gynecology, University Hospital Bonn, Bonn, Germany
| |
Collapse
|
30
|
Jooß A, Haberbosch L, Köhn A, Kozarzewski L, Rönnefarth M, Fleischmann R, Scholz M, Schmidt S, Brandt S. P 63 Investigating the effects of tRNS variants and task dependency on cortical excitability. Clin Neurophysiol 2017. [DOI: 10.1016/j.clinph.2017.06.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Zeynalova S, Scholz M, Tautenhahn S, Wirkner K, Hagendorff A, Loeffler M. Sensitivität von NT-proBNP hinsichtlich Ausschluss einer Herzinsuffizienz. Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- S Zeynalova
- Universität Leipzig, IMISE, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
| | - M Scholz
- Universität Leipzig, IMISE, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
| | - S Tautenhahn
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
| | - K Wirkner
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
| | - A Hagendorff
- Universitätsklinikum Leipzig, Kardiologie und Angiologie, Leipzig
| | - M Loeffler
- Universität Leipzig, IMISE, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
| |
Collapse
|
32
|
Kühnapfel A, Scholz M. Körperoberflächenmessung mittels lasergestützter 3D-Anthropometrie: Reliabilität, Validität und Verbesserung empirischer Oberflächenformeln. Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- A Kühnapfel
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum für Zivilisationserkrankungen, Leipzig
| | - M Scholz
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum für Zivilisationserkrankungen, Leipzig
| |
Collapse
|
33
|
Kühnapfel A, Scholz M. Reliabilität lasergestützter 3D-Körpervermessung und Vergleich mit klassischer Anthropometrie. Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605797] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- A Kühnapfel
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum für Zivilisationserkrankungen, Leipzig
| | - M Scholz
- Universität Leipzig, Institut für Medizinische Informatik, Statistik und Epidemiologie, Leipzig
- Universität Leipzig, Leipziger Forschungszentrum für Zivilisationserkrankungen, Leipzig
| |
Collapse
|
34
|
Zeynalova S, Teren A, Henger S, Burkhardt R, Thiery J, Scholz M. Ergänzung des ARRIBA-Scores zur besseren Prädiktion der Mortalität (LIFE-Heart Studie). Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- S Zeynalova
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
- Universität Leipzig, IMISE, Leipzig
| | - A Teren
- Herzzentrum Leipzig – Universitätsklinik, Leipzig
| | - S Henger
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
- Universität Leipzig, IMISE, Leipzig
| | - R Burkhardt
- Universität Leipzig, Institut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Leipzig
| | - J Thiery
- Universität Leipzig, Institut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Leipzig
| | - M Scholz
- Universität Leipzig, Leipziger Forschungszentrum (LIFE), Leipzig
- Universität Leipzig, IMISE, Leipzig
| |
Collapse
|
35
|
Courdi A, Bensadoun RJ, Scholz M. Radiosensibilité in vitro des cellules tumorales humaines aux particules lourdes chargées. ACTA ACUST UNITED AC 2017. [DOI: 10.1051/jcp/1993901001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
36
|
Saager M, Peschke P, Brons S, Scholz M, Huber P, Debus J, Karger C. OC-0517: Investigation of the RBE variation of protons in the rat spinal cord within a spread-out Bragg peak. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30957-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
37
|
Schreiber L, Rapp M, Sabel M, Onken J, Misch M, Kinzel A, Thomé C, Scholz M, Vajkoczy P, Freyschlag CF. P09.07 The use of programmable shunts in patients treated with Tumor Treating Fields: Multicentric Case Series. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox036.265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
38
|
Zhong Y, Ostach D, Scholz M, Epp SW, Techert S, Schlichting I, Ullrich J, Krasniqi FS. Hot carrier relaxation in CdTe via phonon-plasmon modes. J Phys Condens Matter 2017; 29:095701. [PMID: 27991427 DOI: 10.1088/1361-648x/aa5478] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Carrier and lattice dynamics of laser excited CdTe was studied by time-resolved reflectivity for excitation fluences spanning about three orders of magnitude, from 0.064 to 6.14 mJ cm-2. At fluences below 1 mJ cm-2 the transient reflectivity is dominated by the dynamics of hybrid phonon-plasmon modes. At fluences above 1 mJ cm-2 the time-dependent reflectivity curves show a complex interplay between band-gap renormalization, band filling, carrier dynamics and recombination. A framework that accounts for such complex dynamics is presented and used to model the time-dependent reflectivity data. This model suggests that the excess energy of the laser-excited hot carriers is reduced much more efficiently by emitting hybrid phonon-plasmon modes rather than bare longitudinal optical phonons.
Collapse
Affiliation(s)
- Y Zhong
- Max Planck Advanced Study Group at CFEL/DESY, Notkestr. 85, 22607 Hamburg, Germany. Max-Planck-Institut für medizinische Forschung, Jahnstr. 29, 69120 Heidelberg, Germany. Max-Planck-Institut für Struktur und Dynamik der Matterie, Geb. 99 (CFEL), Luruper Chaussee 149, 22761 Hamburg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Hamiko M, Flimmers R, Scholz M, Welz A, Dewald O, Duerr G. Intraoperative ECMO Implantation Reduces Mortality of CABG Surgery in Patients with STEMI. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M. Hamiko
- Cardiac Surgery, University Clinical Centre Bonn, Bonn, Germany
| | - R. Flimmers
- Medical Biometry, Informatics and Epidemiology, University Clinical Centre Bonn, Bonn, Germany
| | - M. Scholz
- Anaesthesiology and Intensive Care Medicine, University Clinical Centre Bonn, Bonn, Germany
| | - A. Welz
- Cardiac Surgery, University Clinical Centre Bonn, Bonn, Germany
| | - O. Dewald
- Cardiac Surgery, University Clinical Centre Bonn, Bonn, Germany
| | - G.D. Duerr
- Cardiac Surgery, University Clinical Centre Bonn, Bonn, Germany
| |
Collapse
|
40
|
Teren A, Kirsten H, Beutner F, Scholz M, Holdt LM, Teupser D, Gutberlet M, Thiery J, Schuler G, Eitel I. Alteration of Multiple Leukocyte Gene Expression Networks is Linked with Magnetic Resonance Markers of Prognosis After Acute ST-Elevation Myocardial Infarction. Sci Rep 2017; 7:41705. [PMID: 28155873 PMCID: PMC5290530 DOI: 10.1038/srep41705] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Accepted: 12/21/2016] [Indexed: 02/02/2023] Open
Abstract
Prognostic relevant pathways of leukocyte involvement in human myocardial ischemic-reperfusion injury are largely unknown. We enrolled 136 patients with ST-elevation myocardial infarction (STEMI) after primary angioplasty within 12 h after onset of symptoms. Following reperfusion, whole blood was collected within a median time interval of 20 h (interquartile range: 15-25 h) for genome-wide gene expression analysis. Subsequent CMR scans were performed using a standard protocol to determine infarct size (IS), area at risk (AAR), myocardial salvage index (MSI) and the extent of late microvascular obstruction (lateMO). We found 398 genes associated with lateMO and two genes with IS. Neither AAR, nor MSI showed significant correlations with gene expression. Genes correlating with lateMO were strongly related to several canonical pathways, including positive regulation of T-cell activation (p = 3.44 × 10-5), and regulation of inflammatory response (p = 1.86 × 10-3). Network analysis of multiple gene expression alterations associated with larger lateMO identified the following functional consequences: facilitated utilisation and decreased concentration of free fatty acid, repressed cell differentiation, enhanced phagocyte movement, increased cell death, vascular disease and compensatory vasculogenesis. In conclusion, the extent of lateMO after acute, reperfused STEMI correlated with altered activation of multiple genes related to fatty acid utilisation, lymphocyte differentiation, phagocyte mobilisation, cell survival, and vascular dysfunction.
Collapse
Affiliation(s)
- A Teren
- Department of Cardiology/Internal Medicine, Heart Center, University of Leipzig, Germany.,LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Germany
| | - H Kirsten
- LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Medical Informatics, Statistic and Epidemiology, University of Leipzig, Germany.,IZI, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany
| | - F Beutner
- Department of Cardiology/Internal Medicine, Heart Center, University of Leipzig, Germany.,LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Germany
| | - M Scholz
- LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Medical Informatics, Statistic and Epidemiology, University of Leipzig, Germany
| | - L M Holdt
- LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Laboratory Medicine, University Hospital Munich (LMU) and Ludwig-Maximilian- University Munich, Germany
| | - D Teupser
- LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Laboratory Medicine, University Hospital Munich (LMU) and Ludwig-Maximilian- University Munich, Germany
| | - M Gutberlet
- Department of Diagnostic and Interventional Radiology, Heart Center, University of Leipzig, Germany
| | - J Thiery
- LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany.,Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig, Germany
| | - G Schuler
- Department of Cardiology/Internal Medicine, Heart Center, University of Leipzig, Germany.,LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Germany
| | - I Eitel
- University Heart Center Lübeck, University of Lübeck, Medical Clinic II (Cardiology, Angiology and Intensive Care Medicine), Lübeck, Germany
| |
Collapse
|
41
|
Trotte W, Scholz M. Über die Fluoreszenz des Azulenium-Ions. Z PHYS CHEM 2017. [DOI: 10.1515/zpch-1959-21211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
42
|
Kreinest M, Scholz M, Trafford P. On-scene treatment of spinal injuries in motor sports. Eur J Trauma Emerg Surg 2016; 43:191-200. [PMID: 28005155 DOI: 10.1007/s00068-016-0749-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2016] [Accepted: 12/12/2016] [Indexed: 12/18/2022]
Abstract
Because spinal cord injuries can have fatal consequences for injured race car drivers, prehospital treatment of spinal injuries is a major concern in motor sports. A structured procedure for assessing trauma patients and their treatment should follow established ABCDE principles. Only then, a stable patient could be further examined and appropriate measures can be undertaken. For patients in an acute life-threatening condition, rapid transport must be initiated and should not be delayed by measures that are not indicated. If a competitor must first be extricated from the racing vehicle, the correct method of extrication must be chosen. To avoid secondary injury to the spine after a racing accident, in-line extrication from the vehicle and immobilization of the patient are standard procedures in motor sports and have been used for decades. Since immobilization can be associated with disadvantages and complications, the need for immobilization of trauma patients outside of motor sports medicine has become the subject of an increasing number of reports in the scientific literature. Even in motor sports, where specific safety systems that offer spinal protection are present, the indications for spinal immobilization need to be carefully considered rather than being blindly adopted as a matter of course. The aim of this article is to use recent literature to present an overview about the treatment of spinal injuries in motor sports. Further, we present a new protocol for indications for immobilizing the spine in motor sports that is based on the ABCDE principles and takes into account the condition of the patient.
Collapse
Affiliation(s)
- M Kreinest
- Department for Trauma Surgery, BG Trauma Center Ludwigshafen, Ludwig-Guttmann-Str. 13, 67071, Ludwigshafen, Germany.
| | - M Scholz
- Department for Orthopedics and Anesthesia, Specialty Hospital Vogelsang-Gommern, Sophie-v.-Boetticher-Straße 1, 39245, Gommern, Germany
| | - P Trafford
- Department of Anesthesia, Arrowe Park Hospital, Arrowe Park Road, Upton, United Kingdom
| |
Collapse
|
43
|
Bielecki J, Wójcik-Gargula A, Scholz M. Conceptual design of the tomographic system for simultaneous studying of soft and hard X-ray emission from dense magnetized plasma. Fusion Engineering and Design 2016. [DOI: 10.1016/j.fusengdes.2016.04.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
44
|
Burger P, Neumann C, Ropohl A, Paulsen F, Scholz M. Development of depression and deterioration in quality of life in German dental medical students in preclinical semesters. Ann Anat 2016; 208:183-186. [DOI: 10.1016/j.aanat.2016.05.011] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2016] [Revised: 05/24/2016] [Accepted: 05/25/2016] [Indexed: 12/20/2022]
|
45
|
Tang X, Li Q, Wu M, Lin L, Scholz M. Review of remediation practices regarding cadmium-enriched farmland soil with particular reference to China. J Environ Manage 2016; 181:646-662. [PMID: 27562701 DOI: 10.1016/j.jenvman.2016.08.043] [Citation(s) in RCA: 85] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/01/2016] [Revised: 08/01/2016] [Accepted: 08/14/2016] [Indexed: 06/06/2023]
Abstract
Cadmium-enrichment of farmland soil greatly threatens the sustainable use of soil resources and the safe cultivation of grain. This review paper briefly introduces the status of farmland soil as well as grain, which are both often polluted by cadmium (Cd) in China, and illustrates the major sources of Cd contaminants in farmland soil. In order to meet soil environmental quality standards and farmland environmental quality evaluation standards for edible agricultural products, Cd-enriched farmland soil is frequently remediated with the following prevailing techniques: dig and fill, electro-kinetic remediation, chemical elution, stabilisation and solidification, phytoremediation, field management and combined remediation. Most remediation techniques are still at the stage of small-scale trial experiments in China and few techniques are assessed in field trials. After comparing the technical and economical applicability among different Cd-enriched farmland soil remediation techniques, a novel ecological and hydraulic remediation technique has been proposed, which integrated the advantages of chemical elution, solidification and stabilisation, phytoremediation and field management. The ecological and hydraulic remediation concept is based on existing irrigation and drainage facilities, ecological ditches (ponds) and agronomic measures, which mainly detoxify the Cd-enriched soil during the interim period of crop cultivation, and guarantee the grain safety during its growth period. This technique may shift the challenge from soil to water treatment, and thus greatly enhances the remediation efficiency and shortens the remediation duration. Moreover, the proposed ecological and hydraulic remediation method matches well with the practical choice of cultivation while remediation for Cd-enriched soil in China, which has negligible impacts on the normal crop cultivation process, and thus shows great potential for large area applications.
Collapse
Affiliation(s)
- X Tang
- Basin Water Environmental Research Department, Changjiang River Scientific Research Institute, Wuhan 430010, China; Key Lab of Basin Water Resource and Eco-Environmental Science in Hubei Province, Wuhan 430010, China; Collaborative Innovation Center for Geo-Hazards and Eco-Environment in Three Gorges Area, Hubei Province, Yichang 443002, China.
| | - Q Li
- Basin Water Environmental Research Department, Changjiang River Scientific Research Institute, Wuhan 430010, China; Key Lab of Basin Water Resource and Eco-Environmental Science in Hubei Province, Wuhan 430010, China
| | - M Wu
- Basin Water Environmental Research Department, Changjiang River Scientific Research Institute, Wuhan 430010, China; Key Lab of Basin Water Resource and Eco-Environmental Science in Hubei Province, Wuhan 430010, China; Collaborative Innovation Center for Geo-Hazards and Eco-Environment in Three Gorges Area, Hubei Province, Yichang 443002, China
| | - L Lin
- Basin Water Environmental Research Department, Changjiang River Scientific Research Institute, Wuhan 430010, China; Key Lab of Basin Water Resource and Eco-Environmental Science in Hubei Province, Wuhan 430010, China
| | - M Scholz
- Division of Water Resources Engineering, Faculty of Engineering, Lund University, P.O. Box 118, 22100 Lund, Sweden; Civil Engineering Research Group, School of Computing, Science and Engineering, The University of Salford, Newton Building, Peel Park Campus, Salford, Greater Manchester M5 4WT, United Kingdom.
| |
Collapse
|
46
|
Jawinski P, Sander C, Spada J, Ulke C, Mauche N, Huang J, Surova G, Burkhardt R, Kirsten H, Scholz M, Hensch T, Hegerl U. FV 15. Genome-wide association study of human brain arousal regulation. Clin Neurophysiol 2016. [DOI: 10.1016/j.clinph.2016.05.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
47
|
Kunnus K, Josefsson I, Rajkovic I, Schreck S, Quevedo W, Beye M, Weniger C, Grübel S, Scholz M, Nordlund D, Zhang W, Hartsock RW, Gaffney KJ, Schlotter WF, Turner JJ, Kennedy B, Hennies F, de Groot FMF, Techert S, Odelius M, Wernet P, Föhlisch A. Identification of the dominant photochemical pathways and mechanistic insights to the ultrafast ligand exchange of Fe(CO)5 to Fe(CO)4EtOH. Struct Dyn 2016; 3:043204. [PMID: 26958587 PMCID: PMC4752567 DOI: 10.1063/1.4941602] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2015] [Accepted: 01/22/2016] [Indexed: 05/19/2023]
Abstract
We utilized femtosecond time-resolved resonant inelastic X-ray scattering and ab initio theory to study the transient electronic structure and the photoinduced molecular dynamics of a model metal carbonyl photocatalyst Fe(CO)5 in ethanol solution. We propose mechanistic explanation for the parallel ultrafast intra-molecular spin crossover and ligation of the Fe(CO)4 which are observed following a charge transfer photoexcitation of Fe(CO)5 as reported in our previous study [Wernet et al., Nature 520, 78 (2015)]. We find that branching of the reaction pathway likely happens in the (1)A1 state of Fe(CO)4. A sub-picosecond time constant of the spin crossover from (1)B2 to (3)B2 is rationalized by the proposed (1)B2 → (1)A1 → (3)B2 mechanism. Ultrafast ligation of the (1)B2 Fe(CO)4 state is significantly faster than the spin-forbidden and diffusion limited ligation process occurring from the (3)B2 Fe(CO)4 ground state that has been observed in the previous studies. We propose that the ultrafast ligation occurs via (1)B2 → (1)A1 → (1)A' Fe(CO)4EtOH pathway and the time scale of the (1)A1 Fe(CO)4 state ligation is governed by the solute-solvent collision frequency. Our study emphasizes the importance of understanding the interaction of molecular excited states with the surrounding environment to explain the relaxation pathways of photoexcited metal carbonyls in solution.
Collapse
Affiliation(s)
| | - I Josefsson
- Department of Physics, Stockholm University , AlbaNova University Centre, 10691 Stockholm, Sweden
| | - I Rajkovic
- Max Planck Institute for Biophysical Chemistry , Am Fassberg 11, 37070 Göttingen, Germany
| | | | - W Quevedo
- Institute for Methods and Instrumentation for Synchrotron Radiation Research , Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Albert-Einstein-Strasse 15, 12489 Berlin, Germany
| | - M Beye
- Institute for Methods and Instrumentation for Synchrotron Radiation Research , Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Albert-Einstein-Strasse 15, 12489 Berlin, Germany
| | - C Weniger
- Institute for Methods and Instrumentation for Synchrotron Radiation Research , Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Albert-Einstein-Strasse 15, 12489 Berlin, Germany
| | - S Grübel
- Max Planck Institute for Biophysical Chemistry , Am Fassberg 11, 37070 Göttingen, Germany
| | - M Scholz
- Max Planck Institute for Biophysical Chemistry , Am Fassberg 11, 37070 Göttingen, Germany
| | - D Nordlund
- Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory , Menlo Park, California 94025, USA
| | - W Zhang
- PULSE Institute , SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - R W Hartsock
- PULSE Institute , SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - K J Gaffney
- PULSE Institute , SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - W F Schlotter
- Linac Coherent Light Source, SLAC National Accelerator Laboratory , Menlo Park, California 94025, USA
| | - J J Turner
- Linac Coherent Light Source, SLAC National Accelerator Laboratory , Menlo Park, California 94025, USA
| | - B Kennedy
- Institute for Methods and Instrumentation for Synchrotron Radiation Research , Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Albert-Einstein-Strasse 15, 12489 Berlin, Germany
| | - F Hennies
- MAX-lab , P.O. Box 118, 221 00 Lund, Sweden
| | - F M F de Groot
- Department of Chemistry, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands
| | | | - M Odelius
- Department of Physics, Stockholm University , AlbaNova University Centre, 10691 Stockholm, Sweden
| | - Ph Wernet
- Institute for Methods and Instrumentation for Synchrotron Radiation Research , Helmholtz-Zentrum Berlin für Materialien und Energie GmbH, Albert-Einstein-Strasse 15, 12489 Berlin, Germany
| | | |
Collapse
|
48
|
Moreno JB, Margraf S, Schuller AM, Simon A, Moritz A, Scholz M. Inhibition of neutrophil activity in cardiac surgery with cardiopulmonary bypass: a novel strategy with the leukocyte inhibition module. Perfusion 2016; 19:11-6. [PMID: 15072250 DOI: 10.1191/0267659104pf709oa] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Recently, we showed that the arterial in-line application of the leukocyte inhibition module (LIM) within the heart-lung machine limits overshooting leukocyte activity and cardiac tissue damage. Moreover, significantly better cardiac function was found in an experimental animal model when LIM was used. In the meantime, the first promising clinical data exist. LIM has to be regarded as an essential tool in extracorporeal circulation, in the future, to improve postoperative clinical outcome and to reduce costs. This review summarizes the biological background of LIM and the current experience obtained in experimental models and clinical studies.
Collapse
Affiliation(s)
- José Bitu Moreno
- Department of Vascular Surgery, Medical Faculty of Marília (FAMEMA), Sao Paulo, Brazil
| | | | | | | | | | | |
Collapse
|
49
|
Winkler C, Laimighofer M, Haupt F, D'Orlando O, Jergens S, Scholz M, Krumsiek J, Achenbach P, Ziegler AG. Die Messung von Serumzytokinkonzentrationen verbessert die Stratifizierung der Progressionsrate zum klinisch manifesten Typ 1 Diabetes bei Inselautoantikörper-positiven Kindern. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1584095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
50
|
Michl M, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmueller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Mueller S, Lerch MM, Modest DP, Kirchner T, Jung A, Heinemann V. CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). Ann Oncol 2016; 27:1565-72. [PMID: 27234640 DOI: 10.1093/annonc/mdw222] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2016] [Accepted: 05/19/2016] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND To examine the relation of carcinoembryonic antigen (CEA) response with tumor response and survival in patients with (K)RAS wild-type metastatic colorectal cancer receiving first-line chemotherapy in the FIRE-3 trial comparing FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab. PATIENTS AND METHODS CEA response assessed as the percentage of CEA decrease from baseline to nadir was evaluated for its association with tumor response and survival. Receiver operating characteristic analysis revealed an optimal cut-off value of 75% using the maximum of sensitivity and specificity for CEA response to discriminate CEA responders from non-responders. In addition, the time to CEA nadir was calculated. RESULTS Of 592 patients in the intent-to-treat population, 472 were eligible for analysis of CEA (cetuximab arm: 230 and bevacizumab arm: 242). Maximal relative CEA decrease (%) significantly (P = 0.003) differed between the cetuximab arm (median 83.0%; IQR 40.9%-94.7%) and the bevacizumab arm (median 72.3%; IQR 26.3%-91.0%). In a longitudinal analysis, the CEA decrease occurred faster in the cetuximab arm and was greater than in the bevacizumab arm at all evaluated time points until 56 weeks after treatment start. CEA nadir occurred after 3.3 months (cetuximab arm) and 3.5 months (bevacizumab arm), (P = 0.49). In the cetuximab arm, CEA responders showed a significantly longer progression-free survival [11.8 versus 7.4 months; hazard ratio (HR) 1.53; 95% Cl, 1.15-2.04; P = 0.004] and longer overall survival (36.6 versus 21.3 months; HR 1.73; 95% Cl, 1.24-2.43; P = 0.001) than CEA non-responders. Analysis of extended RAS wild-type patients revealed similar results. CONCLUSION In the FIRE-3 trial, CEA decrease was significantly faster and greater in the cetuximab arm than in the bevacizumab arm and correlated with the prolonged survival observed in patients receiving FOLFIRI plus cetuximab. CLINICAL TRIALS NUMBER NCT00433927 (ClinicalTrials.gov); AIO KRK0306 FIRE-3.
Collapse
Affiliation(s)
- M Michl
- Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich
| | - S Stintzing
- Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg
| | | | - T Decker
- Practice for Hematology and Medical Oncology, Onkonet-Onkologie Ravensburg, Ravensburg
| | - A Kiani
- Department of Hematology and Medical Oncology, Klinik Herzoghöhe, Bayreuth
| | | | - S-E Al-Batran
- Department of Hematology and Medical Oncology, Krankenhaus Nordwest, University Cancer Center Frankfurt, Frankfurt
| | - T Heintges
- Department of Gastroenterology and Oncology, Medical Department II, Lukaskrankenhaus, Städtisches Klinikum Neuss, Neuss
| | | | - C Kahl
- Department of Hematology and Medical Oncology, Klinikum Magdeburg, Magdeburg
| | - G Seipelt
- Practice for Hematology and Medical Oncology, Bad Soden
| | - F Kullmann
- Department of Gastroenterology, Hematology and Medical Oncology, Klinikum Weiden, Weiden
| | - M Stauch
- Practice for Hematology and Medical Oncology, Kronach, Germany
| | - W Scheithauer
- Department of Hematology and Medical Oncology, Medical University of Vienna, Vienna, Austria
| | - J Hielscher
- Department of Surgery, Klinikum Chemnitz, Chemnitz
| | - M Scholz
- Department of Medicine, Klinikum Stuttgart, Stuttgart
| | - S Mueller
- Practice for Hematology and Medical Oncology, Ansbach
| | - M M Lerch
- Department of Medicine A, University Medicine Greifswald, Greifswald
| | - D P Modest
- Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg
| | - T Kirchner
- Department of Pathology, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg
| | - A Jung
- Department of Pathology, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg
| | - V Heinemann
- Department of Hematology and Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center Munich, Ludwig-Maximilians-University Munich, Munich German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg
| | | |
Collapse
|